However, microbiota composition differed between groups ( P = 0.004), with responders and non-responders slightly separated in the PCoA plot ( Figure 1F )
Drugs Exp Clin Res 21, 157159
Oncologist Coral Omene at Rutgers Cancer Institute, for example, plans to follow 40 breast cancer patients starting tirzepatide, a GLP-1 drug sold under the brand names Mounjaro and Zepbound
In 56-week studies, patients taking Contrave alongside diet and exercise lost an average of 5-9% of their body weight, compared to 1-5% with a placebo, meaning the medication contributed roughly 4-5 percentage points of additional weight loss.4,5 About 46% of patients on Contrave achieved at least 5% weight loss by week 16
Prescribers should consider this formulation for patients with hyperpigmentation or other skin discolorations who have not responded to other treatments
Long X, Ye Y, Zhang L, Liu P, Yu W, Wei F, et al